Kent Thoelke is Executive Vice President, Scientific and Medical Affairs, Safety and Commercialization Services. Mr. Thoelke oversees scientific and strategic product development to empower project teams and promote the success of clients’ studies. Mr. Thoelke directs the following PRA divisions: Medical Affairs, Scientific Affairs, Global Feasibility, Medical Informatics, Patient Access and Recruitment Services, Investigator Networks, Orphan and Rare Diseases and the Infectious Disease Research Center. During his tenure at PRA, Mr. Thoelke has served as Vice President of Global Product Development Services and Senior Vice President of Scientific and Medical Affairs. Previously, he worked at Pharmaceutical Product Development, Inc. (PPD), where he held senior-level positions in hematology/oncology, global strategic drug development and corporate development. Mr. Thoelke is also a named inventor on numerous patents in high-dose radiotherapy for the treatment of hematologic malignancies. He has over 21 years of experience in the global drug development, diagnostic and device industries, offering specialized expertise in hematology/oncology studies. Having visited over 40 countries, he is familiar with the global drug development environment, and he has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and drug development timelines. A leader in the field of Medical Informatics, Mr. Thoelke focuses on leveraging data to maximize patient enrollment by selecting high-performing sites to minimize overall drug development timelines.

clinical sciences